Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,667 | 40,947 | 46,485 | 56,409 | 65,889 |
| Marketable Securities | 55,942 | 30,431 | N/A | N/A | N/A |
| TOTAL | $62,991 | $73,622 | $48,904 | $59,518 | $67,565 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 0 | 48,648 |
| Other Non-Current Assets | 33,078 | 33,163 | 33,402 | 33,275 | 33,373 |
| TOTAL | $33,078 | $33,163 | $33,402 | $33,275 | $82,021 |
| Total Assets | $96,069 | $106,785 | $82,306 | $92,793 | $149,586 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 465 | 2,197 | 2,852 | 2,200 | 3,859 |
| Accrued Expenses | 2,038 | 2,313 | 2,242 | 3,912 | 2,043 |
| TOTAL | $2,899 | $4,900 | $5,478 | $6,475 | $6,280 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 83 | 184 | 284 | 383 | 461 |
| TOTAL | $1,835 | $1,936 | $2,036 | $2,135 | $2,213 |
| Total Liabilities | $4,734 | $6,836 | $7,514 | $8,610 | $8,493 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,198 | 23,545 | 22,507 | 13,777 | 13,757 |
| Common Shares | 24 | 23 | 14 | 14 | 14 |
| Retained earnings | -233,565 | -223,216 | -213,637 | -202,865 | -144,481 |
| TOTAL | $91,335 | $99,949 | $74,792 | $84,183 | $141,093 |
| Total Liabilities And Equity | $96,069 | $106,785 | $82,306 | $92,793 | $149,586 |